These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 6356306

  • 21. Preventive symptomatic immunotherapy versus placebo in seasonal rhinitis due to grasses in children and to Parietaria in adult patients.
    Troise C, Bignardi D, Modena P, Pissacroia C, Di Berardino F.
    Allerg Immunol (Paris); 2000 Jun; 32(6):246-9. PubMed ID: 10971859
    [Abstract] [Full Text] [Related]

  • 22. Blind study of basophilic cells in nasal smears from patients with grass pollen hay fever.
    Wihl JA, Brofeldt S, Grønborg H, Borum P, Mygind N.
    Eur J Respir Dis Suppl; 1983 Jun; 128 (Pt 2)():383-6. PubMed ID: 6137401
    [No Abstract] [Full Text] [Related]

  • 23. Treatment of ragweed hay fever with flurbiprofen, a cyclooxygenase-inhibiting drug.
    Brooks CD, Nelson AL, Metzler C.
    Ann Allergy; 1985 Oct; 55(4):557-62. PubMed ID: 3931509
    [Abstract] [Full Text] [Related]

  • 24. A comparison of beclomethasone dipropionate aqueous nasal spray and sodium cromoglycate nasal spray in the management of seasonal allergic rhinitis.
    Morrow-Brown H, Jackson FA, Pover GM.
    Allergol Immunopathol (Madr); 1984 Oct; 12(5):355-61. PubMed ID: 6441477
    [Abstract] [Full Text] [Related]

  • 25. Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit.
    Krug N, Hohlfeld JM, Geldmacher H, Larbig M, Heermann R, Lavallee N, Nguyen DT, Petzold U, Hermann R.
    Allergy; 2005 Mar; 60(3):354-9. PubMed ID: 15679722
    [Abstract] [Full Text] [Related]

  • 26. Clobetasone treatment of allergic conjunctivitis: a comparative double blind study.
    Cerqueti PM, Prosio PE, Bosia S, Buscaglia S, Ciprandi G.
    Allergol Immunopathol (Madr); 1993 Mar; 21(2):67-70. PubMed ID: 8337991
    [Abstract] [Full Text] [Related]

  • 27. Fluticasone furoate versus placebo in symptoms of grass-pollen allergic rhinitis induced by exposure in the Vienna Challenge Chamber.
    Zieglmayer P, Zieglmayer R, Bareille P, Rousell V, Salmon E, Horak F.
    Curr Med Res Opin; 2008 Jun; 24(6):1833-40. PubMed ID: 18498678
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of loratadine versus placebo in the prophylactic treatment of seasonal allergic rhinitis.
    Dolovich J, Moote DW, Mazza JA, Clermont A, PetitClerc C, Danzig M.
    Ann Allergy; 1994 Sep; 73(3):235-9. PubMed ID: 8092558
    [Abstract] [Full Text] [Related]

  • 29. Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule.
    Colás C, Monzón S, Venturini M, Lezaun A.
    J Allergy Clin Immunol; 2006 Apr; 117(4):810-6. PubMed ID: 16630938
    [Abstract] [Full Text] [Related]

  • 30. Monoid sublingual immunotherapy.
    Palma-Carlos AG, Santos AS, Branco-Ferreira M, Pregal AL, Palma-Carlos ML.
    Eur Ann Allergy Clin Immunol; 2006 Mar; 38(3):87-9. PubMed ID: 16752693
    [Abstract] [Full Text] [Related]

  • 31. Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma.
    Dahl R, Nielsen LP, Kips J, Foresi A, Cauwenberge P, Tudoric N, Howarth P, Richards DH, Williams M, Pauwels R, SPIRA Study Group.
    Allergy; 2005 Jul; 60(7):875-81. PubMed ID: 15932376
    [Abstract] [Full Text] [Related]

  • 32. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
    Panzner P, Petrás M, Sýkora T, Lesná I.
    Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of FCB, BDP, and DSCG in allergen inhalation challenge test.
    Wüthrich B, Chen-Walden H.
    Int J Clin Pharmacol Ther Toxicol; 1982 Dec; 20(12):595-9. PubMed ID: 6818164
    [Abstract] [Full Text] [Related]

  • 34. Intranasal fluocortin butyl in patients with perennial rhinitis: a 12-month efficacy and safety study including nasal biopsy.
    Orgel HA, Meltzer EO, Bierman CW, Bronsky E, Connell JT, Lieberman PL, Nathan R, Pearlman DS, Pence HL, Slavin RG.
    J Allergy Clin Immunol; 1991 Aug; 88(2):257-64. PubMed ID: 1880325
    [Abstract] [Full Text] [Related]

  • 35. Double-blind trials of inhaled beclomethasone diproprionate and fluocortin butyl ester in allergen-induced immediate and late asthmatic reactions.
    Burge PS, Efthimiou J, Turner-Warwick M, Nelmes PT.
    Clin Allergy; 1982 Nov; 12(6):523-31. PubMed ID: 6758982
    [Abstract] [Full Text] [Related]

  • 36. A comparison of sodium cromoglycate nasal solution and powder in hay fever.
    Manners BT.
    Br J Clin Pract; 1975 Jun; 29(6):153-4. PubMed ID: 805597
    [No Abstract] [Full Text] [Related]

  • 37. [Effect of fluocortin butylester (0.75%) as an ointment in the pyrexal erythema test on human skin (author's transl)].
    Heite HJ, Etspüler J.
    Arzneimittelforschung; 1977 Jun; 27(11a):2234-5. PubMed ID: 580035
    [Abstract] [Full Text] [Related]

  • 38. [Treatment of pollen-induced hay fever with a new antihistaminic preparation phencarol].
    Voronkin VF, Chekanova OA.
    Vestn Otorinolaringol; 1980 Jun; (6):55-8. PubMed ID: 6109389
    [No Abstract] [Full Text] [Related]

  • 39. [Symptomatic mamagement of hay fever using a new depot crystal suspension].
    Schilffarth H.
    Ther Ggw; 1978 May; 117(5):797-807. PubMed ID: 351843
    [No Abstract] [Full Text] [Related]

  • 40. [Therapeutic effect and effect on the pituitary adrenal functions of fluocortine-butylester in eczema during childhood (author's transl)].
    Favrod-Coune E, Sizonenko PC, Paunier L, Varonier H, Hunziker N.
    Dermatologica; 1978 May; 157(5):297-9. PubMed ID: 150351
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.